Boostrix is a booster vaccine used to prevent tetanus, diphtheria, and pertussis. This eMedTV article offers a complete overview on this drug, including how it works, dosing guidelines, general precautions, possible side effects, and more.
This eMedTV segment explains that there are several potential side effects of Boostrix, including headaches, pain, and fatigue. This page also highlights some of the more serious problems that may require immediate medical attention.
As this eMedTV page explains, Boostrix is a booster vaccine used to prevent tetanus, diphtheria, and pertussis in adults and children as young as 10 years old. This page further discusses these uses for Boostrix, including information on how it works.
The standard Boostrix dosage is one vaccine injected a single time in individuals age 10 to 64 years old. This eMedTV article further discusses dosing guidelines for this vaccine, including a list of factors that may affect when it is given.
As this eMedTV Web page explains, drug interactions may occur when Boostrix is taken with certain other medications, such as immunosuppressants, other vaccines, or tetanus immune globulin. This page also describes the problems that may occur as a result.
This eMedTV segment takes an in-depth look at several Boostrix warnings and precautions, including the risks of taking the drug if you have certain medical conditions. This page also explains what to tell your doctor before receiving this vaccine.
In general, pregnant women should wait until after childbirth to take the Boostrix vaccine. This eMedTV Web resource takes an in-depth look at Boostrix and pregnancy, explaining why this vaccine may not be safe for pregnant women.
As this eMedTV page explains, Boostrix is typically considered safe for use in women who are breastfeeding. This page further explores Boostrix and breastfeeding, including information on why this vaccine is important for women with small children.
Generic "biologic" drugs, including generic Boostrix, are not allowed to be manufactured. This eMedTV page explains why biologics cannot be made into generics and discusses how current legislation may change these rules to allow for generic versions.
